NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:NLH - CA66980G1090 - Common Stock
0.295 CAD
-0.01 (-1.67%)
Overall NLH gets a fundamental rating of 4 out of 10. We evaluated NLH against 14 industry peers in the Health Care Providers & Services industry. NLH has only an average score on both its financial health and profitability. NLH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- NLH had positive earnings in the past year.
- In the past year NLH had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
- In the past 5 years NLH always reported a positive cash flow from operatings.
1.2 Ratios
- NLH's Return On Assets of 3.18% is fine compared to the rest of the industry. NLH outperforms 78.57% of its industry peers.
- NLH has a better Return On Equity (4.00%) than 78.57% of its industry peers.
- The Return On Invested Capital of NLH (4.16%) is better than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 4% | ||
| ROIC | 4.16% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of NLH (2.50%) is better than 71.43% of its industry peers.
- NLH's Profit Margin has declined in the last couple of years.
- NLH has a Operating Margin of 3.56%. This is in the better half of the industry: NLH outperforms 71.43% of its industry peers.
- NLH has a Gross Margin (39.51%) which is in line with its industry peers.
- NLH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.56% | ||
| PM (TTM) | 2.5% | ||
| GM | 39.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NLH is destroying value.
- NLH has more shares outstanding than it did 1 year ago.
- NLH has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for NLH is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.68 indicates that NLH is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.68, NLH belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
- The Debt to FCF ratio of NLH is 1.89, which is an excellent value as it means it would take NLH, only 1.89 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of NLH (1.89) is better than 100.00% of its industry peers.
- NLH has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
- NLH's Debt to Equity ratio of 0.04 is amongst the best of the industry. NLH outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 3.68 |
ROIC/WACC0.53
WACC7.92%
2.3 Liquidity
- NLH has a Current Ratio of 0.93. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
- With an excellent Current ratio value of 0.93, NLH belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
- A Quick Ratio of 0.93 indicates that NLH may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.93, NLH belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 260.00% over the past year.
- The earnings per share for NLH have been decreasing by -11.19% on average. This is quite bad
- Looking at the last year, NLH shows a quite strong growth in Revenue. The Revenue has grown by 16.47% in the last year.
- Measured over the past years, NLH shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)260%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%304.17%
Revenue 1Y (TTM)16.47%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%29%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 29.50, NLH can be considered very expensive at the moment.
- 71.43% of the companies in the same industry are more expensive than NLH, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of NLH to the average of the S&P500 Index (28.60), we can say NLH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NLH is valued cheaper than 85.71% of the companies in the same industry.
- 71.43% of the companies in the same industry are more expensive than NLH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.82 | ||
| EV/EBITDA | 10.94 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for NLH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NOVA LEAP HEALTH CORP / NLH.CA FAQ
What is the ChartMill fundamental rating of NOVA LEAP HEALTH CORP (NLH.CA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NLH.CA.
What is the valuation status of NOVA LEAP HEALTH CORP (NLH.CA) stock?
ChartMill assigns a valuation rating of 3 / 10 to NOVA LEAP HEALTH CORP (NLH.CA). This can be considered as Overvalued.
How profitable is NOVA LEAP HEALTH CORP (NLH.CA) stock?
NOVA LEAP HEALTH CORP (NLH.CA) has a profitability rating of 5 / 10.
What is the valuation of NOVA LEAP HEALTH CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NOVA LEAP HEALTH CORP (NLH.CA) is 29.5 and the Price/Book (PB) ratio is 1.